This page shows the latest Future pharma news and features for those working in and with pharma, biotech and healthcare.
Well, because they are really good examples of – and therefore evidence of – industry phenomena that I observed and predicted, first in my 2011 book ‘The Future of Pharma’ and then its ... The future shaper. Firstly, I wrote about the rising
4. Alignment and efficiency. We are acutely aware that beyond HCPs, pharma clients themselves are an audience. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.
But we are also setting [them] out as transparently as we possibly can so people know the sort of things we might have to do in future.”. ... A number of pharma companies are currently undertaking research into possible vaccine candidates, including
It fired the pair on 13 August. While pharma companies often allow biotechs they acquire to retain independence in order to preserve the agility and ingenuity that made them attractive targets, ... Novartis has decided it will shift AveXis’ quality
Will acquire Semma Therapeutics for $950m. American pharma company Vertex will acquire Semma Therapeutics, a biotech focused on finding a cure for type 1 diabetes. . ... Vertex paid $245m upfront for the CRISPR/Cas-9-focused company, with another $750m
2019 has already been very eventful in terms of the debate about pharma’s future, including the question of how to proceed with plans for harmonisation of health technology assessment (HTA) ... Another major controversy was the introduction of a new
More from news
Approximately 0 fully matching, plus 145 partially matching documents found.
Figure 1. As Neils Bohr famously joked, predictions are difficult, especially about the future. ... But can we use science to predict the future of our whole industry?
The future of pharma. Drug metabolism rates vary between patients. Some patients metabolise a drug so rapidly that therapeutically effective blood and tissue concentrations are not reached; in others, metabolism may ... We are still in the early stages,
Considering the future of the trial master file in the light of COVID-19 and accelerated digital transformation. ... On the contrary, it has an important part to play in pharma’s future.
Consider future business trips. Pharma businesses will be used to their European colleagues coming across to the UK and British nationals travelling to Europe – for example, to collaborate on projects for ... Frontier workers. Pharma businesses may
Seen as the future of pharma for many years, cell and gene therapy (C>) is finally coming of age – advances in technology and new commercial viability mean we are closer ... hangover of big pharma being left behind in the sphere of monoclonal
More from intelligence
Approximately 0 fully matching, plus 57 partially matching documents found.
Gitte Aabo, president and chief executive officer of Leo Pharma, said: “Rhonda has extensive experience in pharmaceutical supply chain management, and she knows Leo Pharma really well. ... Duffy initially joined Leo Pharma back in 1993 and was
I’m delighted to be joining Future Thinking and helping its clients navigate the opportunities and challenges that lie ahead for the sector.”. ... Working with Future Thinking is a great oppitunity to help healthcare organisations deliver the best
and management experience, which will be an invaluable asset for PLx Pharma's success and future growth prospects. ... Giordano said: “I am excited to be joining PLx Pharma at this critical pre-launch inflection point.”.
Morton was most recently chief executive at oncology specialist EUSA Pharma – a company he also founded. ... Commenting on the future of Glide Pharma under his direction Morton said: "Having completed a significant investment round earlier this year
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Bogi Eliasen, Director of Health at Copenhagen Institute for Futures Studies, discusses the future of genomics, personalized health, healthcare data, digital health, and more.
Our purpose is to design remote educatation and learning programs that orientate Pharma clients and agencies around the future potential of digital and emerging technologies for a post pandemic world.
Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder &CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices. Among many other things, we
Looking to the future, even when the pandemic is over, there is a sense that pharma’s style of engagement with the NHS has already changed forever. ... However, it is clear that digital is the future for HCPs, patients and pharma alike and that
Andree Bates, Founder &CEO of Eularis, and discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. ... Among many other interesting topics, they dissect the
More from PMHub
Approximately 3 fully matching, plus 39 partially matching documents found.
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....